Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when GXO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsGXO reports Q2 revenue up 4.3% to $3.4B, new business wins surge 34% to $410M
Filed August 4, 2026 · Period ending August 4, 2026 · ~1 min read
Key Changes
-
high
New business wins jumped 34% YoY to $410M in Q2, the strongest quarter in three years, with 40% from strategic growth verticals (aerospace, tech, industrial, life sciences).
Exhibit 99.1 view on EDGAR → -
high
Secured $1B of incremental 2026 revenue (up 29% YoY) and $353M for 2027, providing strong forward visibility; North America first-half wins up 85% over prior year.
Exhibit 99.1 view on EDGAR → -
high
Q2 revenue rose 4.3% to $3.4B with 3.4% organic growth across all three regions; adjusted EBITDA increased to $219M from $212M, adjusted EPS to $0.59 from $0.57.
Exhibit 99.1 view on EDGAR → -
medium
Maintained full-year adjusted EBITDA guidance at $945M–$965M (mid-point $955M) and adjusted EPS at $2.95–$3.15 (mid-point $3.05), narrowing ranges while holding mid-points.
Exhibit 99.1 view on EDGAR →
Summary
GXO reported strong commercial momentum in Q2 2026, with new business wins of $410 million representing a 34% year-over-year increase and the best quarterly performance in three years. The company is successfully diversifying its customer base, with 40% of new wins coming from strategic growth verticals including aerospace & defense, technology, industrial, and life sciences.
North America showed particularly strong momentum with first-half wins up 85% over the prior year. The company has secured approximately $1 billion of incremental 2026 revenue (up 29% year-over-year) and $353 million for 2027, providing clear visibility into future performance. Q2 revenue of $3.4 billion grew 4.3% year-over-year with 3.4% organic growth across all regions.
Adjusted EBITDA rose to $219 million from $212 million, and adjusted EPS increased to $0.59 from $0.57. GXO maintained the mid-points of its full-year guidance for adjusted EBITDA ($955 million) and adjusted EPS ($3.05) while narrowing the ranges, signaling confidence in execution. The combination of accelerating new business wins, strong revenue visibility into 2027, and maintained guidance suggests the company is executing well on its growth strategy and diversification efforts.
Section-by-Section Diff
Event · Exhibit 99.1
GXO reports Q2 2026 revenue of $3.4B (up 4.3% YoY), $410M new business wins (up 34% YoY), and maintains full-year adjusted EBITDA and EPS guidance.
Added in current filing · view on EDGAR → · paraphrased
Revenue increased to $3.4 billion, up 4.3% year over year, compared with $3.3 billion for the second quarter 2025. Organic revenue grew by 3.4%.
GXO reported second quarter 2026 revenue of $3.4 billion, a 4.3% increase from $3.3 billion in Q2 2025. Organic revenue growth, which excludes foreign exchange impacts, was 3.4%. All three geographic regions contributed to organic growth, demonstrating the resilience of GXO's business model.
Added in current filing · view on EDGAR → · paraphrased
Organic revenue growth of 4% to 5%; Adjusted EBITDA of $945 million to $965 million (previously $935 million to $975 million); Adjusted diluted EPS of $2.95 to $3.15 (previously $2.90 to $3.20); and Free cash flow conversion of 30% to 40%.
GXO updated its full-year 2026 guidance, maintaining the mid-points for adjusted EBITDA ($955 million) and adjusted diluted EPS ($3.05) while narrowing the ranges. The company expects organic revenue growth of 4% to 5% and free cash flow conversion of 30% to 40%, reflecting confidence in execution despite a tightened guidance range.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 5, 2026 · How we verify